CRISPR Therapeutics AG

CRISPR Therapeutics AG

World Rank (Aug-2026)
3545
Market Cap (Aug-2026)
5.178 Billion USD
Market Cap (Mar-08-2026)
5.423 Billion USD
World Rank (Jan-05-2024)
2,937
Market Cap (Jan-05-2024)
4.970 Billion USD
World Rank (Jul-30-2023)
3,257
Market Cap (Jul-30-2023)
4.491 Billion USD
World Rank (Jan-07-2022)
3,187
Market Cap (Jan-07-2022)
5.178 Billion USD
World Rank (Jan-01-2021)
1,581
Market Cap (Jan-01-2021)
10.903 Billion USD
Headquarters Country
Switzerland
Top Healthcare Companies in Europe
Top Technology Companies in Europe
Nasdaq / NYSE Code
CRSP
Employee Count
458
Employee Count as of Date
As on 2022
World Region
Europe
World Subregion
Western Europe
Annual Revenue in USD
0 Million USD
Annual Operating Income in USD
-665 Million USD
Annual Net Income in USD
-582 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
2,265 Million USD
Total Liabilities in USD
343 Million USD
Total Equity in USD
1,922 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Technology
HealthCare Products
Company Website
CRISPR THERAPEUTICS AG
Yahoo
Yahoo @ Nasdaq
Company Profile

Biotechnology company and gene editing company to control couple of human diseases like Cancer and couple of other diseases and it's headquarters is in Switzerland.

With CRISPR/Cas9, they aim to target the source of genetically-defined diseases and engineer the next generation of cellular therapies

Founded Year
2013
IPO Year
2016
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Share